The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/39259
StudyName: Eligibility Eosinophilic Asthma NCT01290887
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 13.12.2019
License: Creative Commons BY 4.0

----

Description: 
Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT01290887
